[1] 安杰,温盛燕,佘强.负荷他汀类药物对急性ST段抬高型心肌梗死患者介入治疗术后疗效的Meta分析[J].第三军医大学学报, 2017,39(23):2316-2322. [2] 汤玮,赵冬婧,胡硕强,等.急性ST段抬高型心肌梗死患者急诊PCI术前80 mg阿托伐他汀治疗对炎性因子及心功能的影响[J].中华临床医师杂志(电子版),2016,10(15):2245-2250. [3] 沈迎,张瑞岩,沈卫峰.急性ST段抬高心肌梗死介入治疗策略:争议与思考[J].中国介入心脏病学杂志,2015,23(3):121-124. [4] 中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST 段抬高型心肌梗死诊断和治疗指南[J].中华心血管病杂志, 2010,38(8):675-690. [5] 葛广豪,龚勇,马江伟,等.不同负荷剂量他汀类药物对老年急性心肌梗死直接介入治疗术后心肌细胞的影响[J].中华老年心脑血管病杂志,2016,18(9):899-904. [6] 杨勇,刘英,刘惠亮,等.急诊PCI术前阿托伐他汀强化治疗对STEMI患者血清炎症因子的影响[J].心血管康复医学杂志,2012,21(3):290-294. [7] 徐晓蓉,李奎宝,王攀,等.不同剂量阿托伐他汀对急性ST段抬高型心肌梗死患者血小板反应性的影响[J].中国循环杂志,2017,32(1):26-30. [8] Wang J, Wang AR, Zhang MJ,et al. Effects of Atorvastatin on Serum High-Sensitive C-Reactive Protein and Total Cholesterol Levels in Asian Patients With Atrial Fibrillation[J].Am J Ther,2017,24(1): 20-29. [9] Kim EK, Hahn JY, Song YB, et al. Effects of high-dose atorvastatin pretreatment in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a cardiac magnetic resonance study[J].J Korean Med Sci,2015, 30(4):435-441. [10] Stone NJ,Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to re-duce atherosclerotic cardiovascular risk in adults;a report of the American College of Cardiology/American Heart Associ-ation Task Force on Practice Guidelines[J].J Am Coll Cardiol,2014,63(25 Pt B):2889-2934. [11] 霍勇,葛均波,韩雅玲,等.急性冠状动脉综合征患者强化他汀治疗专家共识[J].中国介入心脏病学杂志,2014,22(1):4-6.